RxDoctor Payments Data

Katelyn Willis, PA

Medical · Reading, PANPI 1265735500

Payments from drug & device makers

$532in general payments, 2019–2025

Across 26 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$123
  • Novo Nordisk$122
  • Lilly USA, LLC$68
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$41
  • Boehringer Ingelheim$35
  • Amgen$31
  • plus $114 from 5 others

What the payments were for

  • Food & beverage$532100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$532 in reported general payments places this provider in the 55th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$56,047
Medicare patients
200
Services billed
600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$44,718
MounjaroTirzepatide24$28,693
JardianceEmpagliflozin22$26,937
EliquisApixaban25$20,952
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,674
Atorvastatin Calcium150$1,662
Gabapentin94$1,465
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,440
Albuterol Sulfate HfaAlbuterol Sulfate62$1,392
Metformin Hcl ErMetformin Hcl70$1,289
Omeprazole81$1,125
Bupropion XlBupropion Hcl17$1,034
SynthroidLevothyroxine Sodium22$989
Losartan Potassium87$949
Fluticasone Propionate38$916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$122$44,71829 claims
Lilly USA, LLCMounjaro$68$28,69324 claims
Boehringer IngelheimJardiance$35$26,93722 claims
PfizerEliquis$24$20,95225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →